Bidan Huang

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

Gastroenterology, Tight Control Management, Clinical Gastroenterology +3

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 544 citations

Anti-inflammatory, Systemic Treatment, Gastroenterology +7

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

Milton Packer, Wilson S. Colucci, Lloyd D. Fisher et al. · JACC Heart Failure · 2013 · 429 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +7

Cardiovascular Safety of Testosterone-Replacement Therapy

A. Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris et al. · New England Journal of Medicine · 2023 · 369 citations

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Geert D’Haens, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 362 citations

Rheumatology, Induction Therapy, Immunology +9